I decided to use UNITY Screen because I have the sickle cell trait and so does my fiance and I passed it down to my two-year-old Roman. And so I wanted to make sure that the baby didn't get the trait or the disease. When I found out that the UNITY test was non-invasive, I kind of had like a sigh of relief.
“
Partner sample not required.
We sequence small fragments of DNA related to your baby that made its way from the placenta into your bloodstream. The test is safe for you and your baby as blood is drawn from your arm.
In most cases, you’ll receive a reassuring, low-risk result. If your result is high-risk, your doctor will go over the result and offer follow-up testing options.
Watch a video to learn how UNITY Screen works. The presence of fetal RhD antigen is reported with aneuploidy NIPT results about a week after lab receipt.
Payton, UNITY Screen Patient
1035 O’Brien Drive, Menlo Park, CA 94025 © 2016 – 2021 BillionToOne Inc. All rights reserved. BillionToOne® Registered in U.S. Patent and Trademark Office
Privacy Policy | Notice of Privacy Practices
ACCREDITATIONS: CLIA: 05D2167800 | CA: 00353741 | MD: 2999 | RI: LCO01527 | PA: 37021 | CAP
Chat with us to learn how UNITY Screen™ helps your practice.
FOR PROVIDERS
UNITY Screen's proprietary technology is the only test that can assess a baby’s risk for recessively inherited conditions, aneuploidies, and the baby’s RhD status.
Speak to a board-certified counselor to learn how UNITY Screen detects baby’s risk.